Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
CEPHALON, INC. v. SUN PHARMACEUTICAL INDUSTRIES, INC. et al
Case Number:
3:11-cv-05474
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
October 07, 2013
Sun Pharma Can't Quell Patent Feud Over Epilepsy Drug
A New Jersey federal judge on Monday refused to dismiss claims against Sun Pharmaceuticals Ltd. in a patent suit over Sun's generic version of Cephalon Inc.'s anti-epilepsy drug, holding that Cephalon's complaint sufficiently claims willful infringement.
-
December 20, 2012
Judge Questions Validity Of Cephalon's Epilepsy Drug Patent
A New Jersey federal judge on Thursday declined to block sales of Sun Pharmaceutical Industries Ltd.'s generic version of Cephalon Inc.'s anti-epilepsy drug, saying Cephalon had failed to prove infringement and raising questions about its patent's validity.
-
February 10, 2012
Delays Cost Cephalon TRO In Anti-Epilepsy Patent Suit
A New Jersey federal judge on Thursday denied Cephalon Inc.'s request for a temporary restraining order blocking sales of Sun Pharmaceutical Industries Ltd.'s generic version of an anti-epilepsy drug, saying the Pennsylvania drugmaker's delay in bringing the patent infringement suit weighed against early judicial intervention.
-
September 22, 2011
Cephalon Challenges Sun's Anti-Epilepsy Generic
Cephalon Inc. hit Sun Pharmaceutical Industries Inc. with a suit in New Jersey federal court Wednesday alleging its attempts to market a generic version of an anti-epilepsy drug infringed a Cephalon patent.